Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

46 results
Display

Biological Therapy for Inflammatory Bowel Disease in Children

Na SY, Shim JO

  • KMID: 2315314
  • Pediatr Gastroenterol Hepatol Nutr.
  • 2012 Mar;15(1):13-18.
The pathogenesis of inflammatory bowel diseases is not very well understood; it is currently thought to be caused by the interaction between genetic factors, environmental factors, intestinal microbes, and immune...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Developmental Strategy for Stem Cell Therapy Products in Regulatory Considerations

Chang IY, Kim KS

Expectation that stem cell therapy products will prove better and more effective in treating a variety of medical conditions continues to drive expanding research efforts. Stem cell therapy products consist...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biological Therapy for the Prevention and Treatment of Postoperative Endoscopic Recurrence in Crohn's Disease: Time for Acceptance?

Kotze PG, Saad-Hossne R

In most patients, postoperative endoscopic recurrence (PER) occurs 1 year after abdominal resection for Crohn's disease (CD). Preventing PER is essential for disease control, as most patients develop further clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advance in tailored treatment of gastric cancer

Jeung HC, Rha SY

  • KMID: 2305795
  • Korean J Med.
  • 2009 Jul;77(1):1-8.
Even the overall incidence is decreasing and the proportion of early gastric cancer is increasing from the national mass screening program, still gastric cancer is the major issue in Korea....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tailored Treatment of Ankylosing Spondylitis

Kim TJ

Ankylosing spondylitis (AS) is a chronic rheumatic disease of the axial skeleton (spine and sacroiliac joints). Only nonsteroidal anti-inflammatory drugs (NSAIDs) and tumor necrosis factor (TNF) alpha inhibitors have currently...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiation Induced Lung Damage : Mechanisms and Clinical Implications

Oh YT

Radiation therapy is one of most important therapeutic modalities for thoracic malignancies. However, radiation-induced lung damage, such as radiation pneumonitis or fibrosis, is a main dose-limiting factor when irradiating the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Novel Pharmacologic Therapies in the Treatment of Systemic Lupus Erythematosus

Shim SC

Systemic lupus erythematosus (lupus) is an autoimmune disease that affects primarily women, especially those of reproductive age. Lupus is a prototypic organ non-specific autoimmune disease that may affect any organ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical treatment of rheumatoid arthritis (I): Nonsteroidal anti-inflammatory drugs, disease modifying antirheumatic drugs and glucocorticoids

Koh EM

The medical treatment of rheumatoid arthritis has been dramatically improved with the advances of newer disease-modifying antirheumatic drugs (DMARDs) and biologic agents during previous decades. To prevent joint damage, it...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Natural Course of Crohn's Disease and Novel Treatment Drugs

Lee JH, Cheon JH

  • KMID: 2267741
  • Korean J Med.
  • 2013 Dec;85(6):578-585.
Crohn's disease is a chronic recurrent inflammatory disease, mainly affecting the gastrointestinal tract. The pathogenesis of inflammatory bowel disease is believed to be caused by the complex interplay of many...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Advances in ulcerative colitis therapy

Jeen YT, Kim J

  • KMID: 2257258
  • Korean J Med.
  • 2009 Jun;76(6):654-660.
Ulcerative colitis is an idiopathic inflammatory bowel disease characterized by colonic mucosal inflammation and chronic relapsing episodes. The initial therapeutic approach depends on both the extent of colonic involvement and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interstitial pneumonitis associated with infliximab therapy in a rheumatoid arthritis patient

Yoo IS, Song JK

  • KMID: 2259128
  • Korean J Med.
  • 2010 Aug;79(2):215-218.
Tumor necrosis factor (TNF)-alpha inhibitors are well-established biological agents for the treatment of a wide variety of chronic autoimmune diseases and inflammatory conditions, including rheumatoid arthritis (RA), ankylosing spondylitis, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease

Park BC, Lim HJ, Kim BS, Lee WJ, Kim DW, Lee SJ

As more rheumatologists and dermatologists have begun to use biological agents such as TNF-alpha blocker, they have confronted an unexpected complication: psoriasis was paradoxically aggravated or induced by the TNF-alpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
B Cell Targeted Therapy in Rheumatic Disease

Suh CH

B cells play an important role in the pathogenesis of autoimmune disease. B cells not only produce pathogenic autoantibodies, but also present self-antigens to T cells and provide costimulatory signals...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunologic Evaluation of Drug Allergy

Gomez E, Torres MJ, Mayorga C, Blanca M

Hypersensitivity drug reactions (HDR) consist of an individual abnormal response with the involvement of the immunological system. In addition to specific immunological mechanisms where specific antibodies or sensitised T cells...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Targeted Therapy in Inflammatory Bowel Disease; Current Status and Future Perspectives

Jang BI

Novel biologic agents that selectively target specific molecules and pathways have been developed recently for the management of inflammatory bowel disease (IBD). Anti-TNF-alpha, an antibody to TNF-alpha is one of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical treatment of rheumatoid arthritis (II): current biologic agents and newly developing drugs

Kim J, Song YW

Disease-modifying antirheumatic drugs (DMARD) have been used to treat rheumatoid arthritis (RA). However, they have limited efficacy and a considerable adverse event profile. Excess production of soluble cytokines, including tumor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular Imaging of Biological Gene Delivery Vehicles for Targeted Cancer Therapy: Beyond Viral Vectors

Min JJ, Nguyen VH, Gambhir SS

  • KMID: 2051961
  • Nucl Med Mol Imaging.
  • 2010 Apr;44(1):15-24.
Cancer persists as one of the most devastating diseases in the world. Problems including metastasis and tumor resistance to chemotherapy and radiotherapy have seriously limited the therapeutic effects of present...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Computational Approach for the Analysis of Post-PKS Glycosylation Step

Kim KB, Park K

  • KMID: 2166422
  • Genomics Inform.
  • 2008 Dec;6(4):223-226.
We introduce a computational approach for analysis of glycosylation in Post-PKS tailoring steps. It is a computational method to predict the deoxysugar biosynthesis unit pathway and the substrate specificity of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemoprevention of Gastrointestinal Cancer: The Reality and the Dream

Chun KS, Kim EH, Lee S, Hahm KB

  • KMID: 2135063
  • Gut Liver.
  • 2013 Mar;7(2):137-149.
Despite substantial progress in screening, early diagnosis, and the development of noninvasive technology, gastrointestinal (GI) cancer remains a major cause of cancer-associated mortality. Chemoprevention is thought to be a realistic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Atopic Dermatitis: an Update and Review of the Literature

Kim TY

  • KMID: 1474532
  • Pediatr Allergy Respir Dis.
  • 2009 Sep;19(3):209-219.
Atopic dermatitis is a chronic, relapsing, inflammatory skin disease, with genetic and environmental backgrounds. Successful management of atopic dermatitis requires a multipronged approach. Management should compromise of a disease-adapted treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr